Christopher Patriquin

Assistant Professor

University Health Network

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Patriquin is an Assistant Professor at the University Health Network in Canada. His research focuses on paroxysmal nocturnal hemoglobinuria (PNH), with recent publications addressing clinically significant extravascular hemolysis, quality of life domains for patients with PNH, and the long-term efficacy of therapies such as ravulizumab and eculizumab. He also explores the impact of therapeutic plasma exchange in lung transplantation and the association between complement-mediated thrombotic microangiopathy and cognitive dysfunction.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Alexander Röth

GERMANY

View details

Ella Huszti

CANADA

View details

Susanne Singer

Full professor

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

Jeff Szer

AUSTRALIA

View details

Adrian M Owen

Professor in Cognitive Neuroscience and Imaging

Western University

CANADA

View details

Timothy Devos

Professor (deeltijds hoofddocent)

KU Leuven

BELGIUM

View details

Theodore E. Warkentin

CANADA

View details

Shih-Han Huang

Associate Professor

Western University

CANADA

View details

Armand Keating

Professor

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Patriquin

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?

Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment

Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: the EPIC program

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH

Characterizing the association between complement-mediated TMA and cognitive dysfunction using MRI and neurocognitive assessment

Impact of intraoperative therapeutic plasma exchange on bleeding in lung transplantation

Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry

Long‐term effectiveness of eculizumab: Data from the International PNH Registry

Outcomes after flow cytometry crossmatch-positive lung transplants managed with perioperative desensitization

Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations

Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD

Acute thrombocytopenia suggesting thrombotic microangiopathy

Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia

Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphoma.

Plasma exchange in TTP: to taper or not to taper.

The practical integration of a hybrid model of ultrasound-guided peripheral venous access in a large apheresis center.

Apheresis education in Canadian residency programs: A needs assessment.

Collaborators (9)

Alexander Röth

Ella Huszti

Susanne Singer

Jeff Szer

Adrian M Owen

Timothy Devos

Theodore E. Warkentin

Shih-Han Huang

Armand Keating

Make your next move.